Roy Winston Net Worth

The estimated Net Worth of Roy Winston is at least $5.6 Milione dollars as of 2 August 2023. Mr. Winston owns over 509 units of Pacira BioSciences Inc stock worth over $681,720 and over the last 5 years he sold PCRX stock worth over $3,310,256. In addition, he makes $1,611,800 as Chief Clinical Officer at Pacira BioSciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Winston PCRX stock SEC Form 4 insiders trading

Roy has made over 10 trades of the Pacira BioSciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 509 units of PCRX stock worth $17,754 on 2 August 2023.

The largest trade he's ever made was selling 22,224 units of Pacira BioSciences Inc stock on 31 March 2021 worth over $1,569,237. On average, Roy trades about 4,635 units every 109 days since 2019. As of 2 August 2023 he still owns at least 52,440 units of Pacira BioSciences Inc stock.

You can see the complete history of Mr. Winston stock trades at the bottom of the page.

Roy Winston biography

Roy Winston serves as Chief Clinical Officer of the Company. He previously served as our Senior Vice President, Anesthesia, Surgery and Medical Affairs from December 2017 until August 2018 and as our Vice President, Anesthesia & Surgical Services from April 2017 until December 2017. Prior to joining Pacira, he founded LaserAway, a national aesthetic dermatology group, and served as its chief executive officer from January 2005 until March 2007. Dr. Winston has served as chief executive officer and president of LaserAway Medical Corp., the management group of LaserAway, since January 2005. Dr. Winston holds a B.A. from the University of Pennsylvania and an M.D. from the Icahn School of Medicine at Mount Sinai.

What is the salary of Roy Winston?

As the Chief Clinical Officer of Pacira BioSciences Inc, the total compensation of Roy Winston at Pacira BioSciences Inc is $1,611,800. There are 4 executives at Pacira BioSciences Inc getting paid more, with David Stack having the highest compensation of $5,806,430.

How old is Roy Winston?

Roy Winston is 59, he's been the Chief Clinical Officer of Pacira BioSciences Inc since 2018. There are 9 older and 12 younger executives at Pacira BioSciences Inc. The oldest executive at Pacira BioSciences Inc is Gary Pace, 72, who is the Independent Director.

What's Roy Winston's mailing address?

Roy's mailing address filed with the SEC is C/O PACIRA BIOSCIENCES, INC., 5401 WEST KENNEDY BOULEVARD, SUITE 890, TAMPA, FL, 33609.

Insiders trading at Pacira BioSciences Inc

Over the last 14 years, insiders at Pacira BioSciences Inc have traded over $321,391,130 worth of Pacira BioSciences Inc stock and bought 2,075,444 units worth $15,133,188 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Carl L Gordon e Andreas Wicki. On average, Pacira BioSciences Inc executives and independent directors trade stock every 13 days with the average trade being worth of $491,036. The most recent stock trade was executed by Marcelo Bigal on 16 August 2024, trading 1,512 units of PCRX stock currently worth $20,034.

What does Pacira BioSciences Inc do?

pacira pharmaceuticals, inc. (nasdaq: pcrx) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. the company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, exparel® (bupivacaine liposome injectable suspension), was commercially launched in the united states in april 2012. exparel and two other products have utilized the pacira proprietary product delivery technology depofoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

Complete history of Mr. Winston stock trades at Pacira BioSciences Inc

Pacira BioSciences Inc executives and stock owners

Pacira BioSciences Inc executives and other stock owners filed with the SEC include:

• David Stack,
  Chairman of the Board, Chief Executive Officer
• Max Reinhardt,
  President
• Dennis McLoughlin,
  Chief Commercial Officer
• Kristen Williams,
  Chief Administrative Officer, Secretary
• Roy Winston,
  Chief Clinical Officer
• David M. Stack,
  Chairman & CEO
• Charles Reinhart,
  Chief Financial Officer
• Dr. Roy Winston M.D.,
  Chief Medical Officer
• Christopher Christie,
  Director
• Max Reinhardt,
  Pres of Rest of World
• Dr. Jonathan Slonin M.D.,
  Chief Clinical Officer
• Kristen Williams,
  Chief Admin. Officer & Sec.
• Charles A. Reinhart III, CPA, M.B.A.,
  Chief Financial Officer
• Paul Hastings,
  Lead Independent Director
• Laura Brege,
  Independent Director
• John Longenecker,
  Independent Director
• Mark Kronenfeld,
  Independent Director
• Yvonne Greenstreet,
  Independent Director
• Mark Froimson,
  Independent Director
• Gary Pace,
  Independent Director
• Susan Mesco,
  IR Contact Officer
• Andreas Wicki,
  Independent Director
• Charles Laranjeira,
  Chief Technical Officer
• Kristen Williams J.D.,
  Chief Admin. Officer & Sec.
• Daryl Gaugler,
  Chief Operating Officer
• Robert J. Weiland,
  Sr. VP of Alliance Management
• Richard Kahr,
  VP of HR
• Charles Laranjeira,
  Chief Technical Officer
• Lauren Bullaro Riker,
  Principal Accounting Officer & VP of Fin.
• Dennis L Winger,
  Director
• Scott Braunstein,
  SVP, Strategy & Corp. Dev.
• Robert J. Weiland,
  Chief Commercial Officer
• Richard Scranton,
  Chief Scientific Officer
• James B Jones,
  SVP & Chief Medical Officer
• James S Scibetta,
  Chief Financial Officer
• Gary Patou,
  Director
• Taunia Markvicka,
  Vice President, Commercial
• Advisors Llc Orbi Med Capit...,
  
• Venture Partners Vi Lp Sand...,
  
• Bio Ventures Iv Qp Lpmpm Bi...,
  
• Bio Ventures Iv Qp Lp Scopa...,
  
• Carl L Gordon,
  Director
• Bio Ventures Iv Qp Lpmpm Bi...,
  
• Venture Partners Vi Lp Sand...,
  
• Luke Evnin,
  Director
• John Pratt,
  General Manager, San Diego
• Vaughn Mgadicke Ansbert Kai...,
  
• Bioventures Cayman Ltd Hbm,
  10% owner
• Fred A Middleton,
  Director
• Venture Partners Vi Lp Sand...,
  
• Venture Partners Vi Lp Sand...,
  
• Abraham Ceesay,
  Director
• Alethia Young,
  Director
• Marcelo Bigal,
  Director
• Michael J. Yang,
  Director
• Donald C. Manning,
  Chief Medical Officer
• Lauren Riker,
  Senior Vice President, Finance
• Anthony Molloy,
  Chief Lgl & Compliance Officer
• Daryl Gaugler,
  Chief Operating Officer
• Ronald J. Jr. Ellis,
  Chief Strategy Officer
• Jonathan Slonin,
  Chief Medical Officer
• Frank D. Lee,
  Chief Executive Officer